Health-related quality of life was assessed using the questionnaire EQ5D, both for patients and the population, and several other health status outcomes were used. Results: At 73%, schizophrenia and schizoaffective disorder were the most common diagnoses in the patient group. The results in patients (n=903) and population (n=7238) showed significant differences in lower EQ5D among patients. According to the definition by the International Diabetes Federation (IDF), elevated blood pressure was the only metabolic risk associated with lower HRQoL in patients. Raised LDL-cholesterol levels were also significantly related to lower HRQoL. Conclusion: patients suffering from psychosis had significantly lower HRQoL regarding all components in EQ5D, except for the pain/discomfort component.
Introduction
Since most patients with long-term psychotic disorders, including schizophrenia, have a lifelong disorder, improved health-related quality of Life (HRQoL) is an important treatment goal (Resnick et al., 2005) . HRQoL encompasses several important dimensions including psychological status, functional abilities, personal well-being and physical health (Cramer et al., 2000) . A number of factors have been studied in relation to HRQoL in psychiatric patients. Lower everyday functioning, greater severity of symptoms and higher education level have been associated with lower QoL (Ruggeri et al., 2005; Skantze, 1998) . Increasing age, however, has been associated with higher HRQoL (Caron et al., 2005) .
The generic health-related quality of life assessment instrument EQ5D has been used in population surveys in many countries (Burstrom et al., 2001; Kind et al., 1998) , and has also been proved valid in patients with schizophrenia (Bobes et al., 2005; Konig et al., 2007) . The EQ5D generates a health profile together with a single index score for HRQoL (Konig et al., 2007) and can detect differences in quality of life among patients with different disease severity (Bobes et al., 2005) .
Various diagnostic criteria for metabolic syndrome have been proposed by different organizations over the past few years. The diagnostic criteria according to IDF (2009) include elevated waist circumference, triglycerides, blood pressure and fasting glucose together with reduced HDL-cholesterol (Alberti et al., 2009) . Metabolic risk factors seem to be related to HRQoL. Studies of patients with psychotic disorders describe a strong correlation between obesity and lower subjective HRQoL (Faulkner et al., 2007; Strassnig et al., 2003) .
Patients with schizophrenia have a 15-20 percent shorter life expectancy than the general population (Crump et al., 2013; Marder et al., 2004) . The main explanation is linked to the consequences of metabolic risk factors and subsequent development of cardiovascular diseases (Crump et al., 2013; Laursen et al., 2012) . Individuals with psychosis have up to two time's higher prevalence of type 2 diabetes, hypertension and obesity than the general population (McEvoy et al., 2010; Newcomer, 2005) .
Previous research shows an association between prevalence of different risk factors for metabolic syndrome and lower HRQoL in patients with depression and anxiety (Roohafza et al., 2012) . Both men and women with metabolic syndrome had lower HRQoL compared with controls without the metabolic syndrome in a non-disease specific population study (Frisman and Kristenson, 2009) . It is therefore important to study the influence of metabolic risk factors also in patients with psychotic disorders due to the increased risk of influence on HRQoL and the association with high morbidity.
The aim of this study was to compare HRQoL in patients with psychosis, especially schizophrenia, with a reference sample and to analyze the relationship between HRQoL and metabolic risk factors in these patients.
Methods

2:1 Patients
A sample of 903 patients was included. The patients, aged over 18, were consecutively invited to participate in the study when visiting specialized psychiatric outpatient departments for patients with long-term psychotic disorders in the County of Stockholm and six other locations in Sweden between 2005 and 2012. They were diagnosed with schizophrenia or other long-term psychotic disorders (ICD10). Seventy-three percent were diagnosed with schizophrenia or schizoaffective syndrome, 21 percent with other forms of psychosis, and 6 percent with bipolar disorder (Table 2) (Guy et al., 1970) .
. Somatic health was assessed with an own developed questionnaire about cardiovascular disease, diabetes and hypertension. Data on patients' current medication for these conditions were collected. The questionnaire also included questions on smoking habits and alcohol consumption. We have only presented data on alcohol consumption and smoking habits in this article. Blood pressure was taken in the supine position. Weight was measured with a calibrated weight scale. Body height and weight, as well as waist circumference were measured, and BMI was calculated. Blood samples were drawn with the subjects fasting and subsequently analyzed using routine methods at the Karolinska University Hospital laboratory. The laboratory was accredited according to a quality assurance system (Good Laboratory Practice; GLP).
Health-related quality of life was assessed using the EQ5D questionnaire, a standardized instrument for measuring health status (Dolan, 1997) . The EQ5D questionnaire includes five items related to mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Responses in each dimension are divided into three ordinal scales: 1) no problems, 2) moderate problems, and 3) extreme problems. The EQ5D scores were converted into a single summary EQ5D index, which quantifies health status (Brooks, 1996) . The index has a range of -0.594, (lowest HRQoL), to 1.000, (highest HRQoL) and 243 possible health outcomes.
Reference group
A population-based survey sample served as reference group. The survey was conducted in 2006 and included individuals from the general population aged 18 to 84 years. The survey was stratified with respect to age, gender and community, with a total sample size of 13,440.
The reference group was assessed with a self-administrated questionnaire, which included somatic health as well as smoking and alcohol habits. The questionnaire also included selfreported weight, height and EQ5D assessment.
The reference group had a 54 percent response rate (n=7,238). The response rate was lowest among males aged 18-29 years (32%) and highest among both males and females aged 45-64 years (60%) and 65-89 years (69%).
Statistical analysis
All statistical analyses were performed with SPSS 20.0. The distribution of alcohol consumption was severely skewed with 19.3 percent consuming no alcohol in the reference sample and 41.2 percent in the patient group. Thus, comparisons between the groups were performed on stratified data (0 g alcohol per week/non-consumers, 1-199 g /moderate consumers, and >199 g/ high consumers). All variables were summarized with standard descriptive statistics, e.g. mean and frequency. Differences between the reference sample and the patients regarding gender and smoking were analyzed with Pearson's χ-test. Differences in age, alcohol consumption and EQ5D index were analyzed with two-way (group*gender) analysis of variance (ANOVA), since there was a significant difference in the gender distribution (cf. below).
The relationship between HRQoL and BMI was analyzed in a three-way ANOVA (group*gender*BMI-group) with age as a covariate, in which the relationship between the separate factors (group, gender and BMI-group) and the EQ5D index appeared as main effects.
The relationship in HRQoL according to the EQ5D index and the metabolic risk factors was analyzed with a logistic regression analysis (stepwise forward with an inclusion criterion of 0.050). In the analysis, the index was dichotomized according to the median (0.80 vs. >0.80) and used as the dependent or "outcome" variable. All variables constituting the metabolic syndrome (www.idf.org/webdata/docs/MetS_def_update2006.pdf), including the metabolic syndrome per se were entered as independent variables together with gender (gender is female), age (>45 years/Md value), smoking (current), high LDL-cholesterol (>3.4 mmol/L or lipid-decreasing medication) and GAF (>50) all of them coded (0= "No" and 1= "Yes").
Ethics
The procedures were in accordance with the ethical standards of the local ethic review committee and the Declaration of Helsinki of 1964, revised 2008. The protocol was approved by the Regional Ethics Committee at Linköping University (dnr 2004-447/4, 2008/1629-32) All patients gave their informed consent.
Results
Demographic and clinical characteristics
There was a significantly higher proportion of men in the patient group compared to the reference sample (χ 2 = 33.32, p< 0.001). The mean age of the reference sample was 4 years older than that of the patients, but when split according to gender, the age difference was limited to men (M= 52.9 vs. M= 45.1 for men, and M= 49.8 vs. M= 49.1 for women). The interaction effect was thus highly significant [F (1, 8,320 
HRQoL in patients and reference sample
Patients had significantly lower ratings of EQ5D index than the reference sample [F (1, 7,979) = 128.21, p< 0.001] (Table 1) . There was no significant interaction with gender [F (1, 7,979) < 1.00, p= 0.371]. In univariate analysis there was a significant association between EQ5D index and GAF but the correlation was rather weak (r=0.17; p<0.01).
Specific EQ5D ratings were also analyzed with significant differences in mobility health-related quality of life, than the reference group in all comparisons, except for the pain/discomfort rating where the reference group was somewhat lower (p= 0.037).
Taking gender into consideration, the difference in mobility was limited to women, with female patients having more problems (20.2%) than the females in the reference group (15.3%; χ 2 = 6.52, p= 0.011). Furthermore, male patients had more problems with main activities than males in the reference group (29.6% vs 7.8%; χ 2 = 215.64, p<0.101), although the difference was also significant for women (26.8%) vs. 11.9%; χ 2 = 71.53, p< 0.001).
The difference in problems with mobility was limited to the younger group (<44 years), with 11.3 percent in patients and 3.5 percent in the reference sample (χ 2 = 50.92, p< 0.001).
Furthermore, pain/discomfort was greater in the older group with 48.9 percent in the patient group and 66.3 percent in the reference sample (χ 2 = 67.03, p< 0.001).
Relationship between HRQoL and BMI in patients and reference sample
There was a significant relationship between BMI and HRQoL [F(3, 7,617)= 15.30, p< 0.001], with the lowest EQ5D index in the group with the highest BMI (>35) and the highest index in the group with the lowest BMI (<26). There were no significant differences between the two lowest groups (<26 vs 26-30).
Relationship between HRQoL and metabolic risk factors in patients
Within the patient sample, 46 percent fulfilled the criteria for the metabolic syndrome according to IDF(2009) . Among the factors defining the syndrome, waist circumference was most increased, (63 percent), followed by fasting glucose (61 percent), and blood pressure (59 percent) (table 2) . Low GAF score, increased LDL-cholesterol levels and increased blood pressure were associated with lower HRQoL as well as being older than 44 years (table 3) .
Eleven variables were entered as independent variables in the logistic regression analysis:
gender, age (18-44 vs. 45-years), smoking, LDL-cholesterol, global level of functioning (GAF), CGI, and the metabolic risk factors that define the metabolic syndrome (elevated waist circumference, triglycerides, blood pressure and fasting glucose together with reduced HDL cholesterol) (Alberti et al., 2009) . Six variables, lower GAF, lower CGI, higher blood pressure, higher LDL cholesterol levels, age 45+ and female gender, were significantly and independently related to a lower EQ5D index (Table 3) .
Discussion
Main findings
The main finding of this study was that patients suffering from psychosis had significantly lower health-related quality of life compared to a population-based reference group. Among the patients, somewhat surprisingly, only one of the metabolic risk factors in the metabolic syndrome according to the IDF definition (2009), elevated blood pressure, was associated with lower HRQoL. Another metabolic risk factor, not included in the metabolic syndrome, raised LDL-cholesterol, was also associated with lower HRQoL among the patients.
Strength and limitations
Our study was a large cohort study that took place at a number of sites in Sweden. It was a unique opportunity to compare the patient cohort with a large population-based sample. Since the study was cross-sectional, it was not possible to extract any conclusive causal relationships. The low attrition rate in the population study was problematic. However, within the most common age group (40-60 years), the attrition rate was equal to the patient group.
There was also a difference between patients and the general population concerning the administration of the questionnaires. Patients' self-administrated questionnaires were completed at the clinic whereas those of the population were sent out by mail and completed at home. This difference could have caused bias not only in the population-based sample, but also in the patient cohort. Patients may have felt uncomfortable answering the questionnaire reliably in the presence of staff. On the other hand, due to the anonymity of population-based studies, there is always a risk of false response. It would also have been useful and a strength to take the patients antipsychotics into consideration. However, we did not have access to valid data on type of medical treatment.
Comparisons with other studies
Low HRQoL in patients with schizophrenia has been previously reported (Ritsner et al., 2000) . Obesity is generally found to be associated with lowered HRQoL in both healthy individuals and in different patient groups but no such association was found in this study when assessed with obesity measured as waist circumference, while there was an association with BMI. Waist circumference is a part of the metabolic syndrome and is considered to give a better measure of visceral fat than BMI (Despres et al., 2008) .
Increased LDL-cholesterol, which is a strong risk factor for cardiovascular disease but not related to insulin resistance and not included in the metabolic syndrome, was associated with lower HRQoL in patients. This association has not, to our knowledge, been reported previously in patients with psychosis. As this is a cross-sectional study, no causal relationship can be established, higher levels might be both a reason for and an effect of low HRQoL and the mechanisms remain to be further analyzed. A reason for high LDL-cholesterol levels in these patients might be that an unhealthy lifestyle with a possible high intake of saturated fat and carbohydrates is common (Dipasquale et al., 2013) , and that physical activity levels are low. There is also a positive association between levels of LDL-cholesterol and obesity (Klop et al., 2013) . A large proportion of our patients had high BMI. We also found a negative association between high blood pressure and HRQoL. Such an association has previously been found in the general population with hypertension, although the difference compared with normotensive individuals is rather small (Trevisol et al., 2011) . From a clinical perspective, treatment of hypertension seems important as good blood pressure control can improve HRQoL (Zygmuntowicz et al., 2013) .
Other variables significantly related to lower HRQoL among patients were low GAF, older age and female gender. Such associations have been described previously (Caron et al. 2005 , Carpiniello et al. 2012 . The function is assessed in two different ways in GAF and HRQoL, which can be viewed as strength. GAF is assessed by the clinician whereas function in EQ5D
is self-reported. Although significant the association between them was rather weak implying that they measure partly different aspects. In all comparisons of the specific components of EQ5D, the patients had lower HRQoL ratings than the reference group, except for the pain/discomfort rating where the reference group had somewhat lower HRQoL. Most problems in the dimension pain/discomfort in a population group have been reported in an earlier study (Burstrom et al., 2001 ).
Significant proportions of patients with psychosis have developed, or are at risk of developing metabolic syndrome (Meyer and Stahl, 2009 ). In our study, 46 percent of the patients met the criteria for metabolic syndrome according to the IDF (2009) definition.
These high numbers can be related to frequent unhealthy lifestyle choices (Foley and Morley, 2011) , which combined create problematic prerequisites for health and HRQoL.
A comparison between the two groups showed that high BMI and extensive consumption of alcohol were significantly higher in patients than in the reference group. High BMI in patients with schizophrenia is well-known (Fountoulakis et al., 2010; McEvoy et al., 2010) , and is associated with reduced HRQoL (Renzaho et al., 2010) . A study by Strassnig and colleagues (2003) showed reduced HRQoL in both patients with schizophrenia and in controls with high BMI (Strassnig et al., 2003) . These results are in line with our study, which also shows the impact of BMI on HRQoL both in patients and the reference group.
Smoking is another risk factor, and in the present study there was a significantly higher proportion of smokers among the patients compared to the reference sample. This high rate of smoking is in line with findings in another study and smoking is obviously an important risk factor for cardiovascular disease (Bobes et al., 2010) . A Swedish study of lifestyle habits in psychosis within a clinical setting found that 30% of patients were abstainers and 49% were smokers (Cruce and Ojehagen, 2007) . The number of smokers was similar in our study but there were fewer abstainers.
Several studies show that smokers in general have other concurrent problematic lifestyle habits. They drink more alcohol, have lower levels of physical activity, eat less fruit and vegetables and have lower HRQoL (de Miguel Diez et al., 2010; Strine et al., 2005) . The alcohol consumption pattern found among patients in our study, in comparison with the reference group, shows that the majority are either high consumers or non-consumers. These self-reported values can certainly be questioned. This is because health care recommends sobriety when taking antipsychotic medication. This raises the question if the patients' responses are influenced by the care recommendations. At the same time, we know that alcohol has an anti-anxiety effect, at least in the short term, which could explain the high proportion of high consumers.
In line with our study, female gender (Carpiniello et al., 2012) and older age were associated with lower HRQoL (Caron et al., 2005) . On the contrary, another study did not find any gender differences in HRQoL (Heider et al., 2007) . Older age might lead to worse living conditions (Mercier et al., 1998) .
The result of the study shows the need for monitoring physical health and development of intervention programs suitable for this patient group in order to both reduce risk and improve long-term physical health and quality of life. This can be a major challenge as this group may have difficulty maintaining an interest in participating in health interventions (Hultsjo, 2012; Scott and Happell, 2011) . Well-designed trials are required, including further high-quality qualitative research. The trials should also involve fundamental investigations into, for example, the effect of interventions on physical health. There is no acceptable reason for the health care system to accept poorer physical health in patients with psychosis than in the general population.
Conclusion
The study shows that patients suffering from psychosis have significantly lower HRQoL regarding all components in EQ5D, except for the pain/discomfort component, in comparison with the reference sample. According to the IDF (2009) definition, almost half of the patient group met the criteria for metabolic syndrome. The only risk factor included in the metabolic syndrome that was associated with HRQoL was elevated blood pressure. Raised LDLcholesterol was also related to lower HRQoL, together with low GAF, older age, high BMI and female gender. The overall situation is problematic as these patients are at great additional risks for physical comorbidity. 
